A diagnosis of Kaposi sarcoma is a significant life event, but it is a manageable condition. Because KS is so closely linked ...

Dr. Alex Francoeur, an oncology fellow at the University of California Irvine, encourages patients with ovarian cancer to ask questions, seek second opinions if needed and build strong relationships ...

Dr. Rodney Haring sat down with CURE for an interview to discuss a critical disparity in U.S. cancer outcomes. While overall survival rates are improving nationwide, Native American people continue to ...

A study led by Dr. J. William Harbour of UT Southwestern Medical Center marks a shift in how doctors predict the spread of uveal melanoma.

Gratitude was operationalized as an intentional attentional practice that supported emotional coping and steadiness during prognostic uncertainty rather than eliminating fear. Gratitude didn’t erase ...

The study highlights that combining the DecisionDx-UM test with PRAME expression is superior to standard mutation analysis. And for a patient who's just been diagnosed with uveal melanoma, what does ...

Dr. Shaun P. McKenzie discusses bile duct cancer challenges and why awareness and specialized care help patients get ...

As treatment options for acute myeloid leukemia (AML) evolve, new therapies could change the patient experience around ...

Resistant cells demonstrated global decreases in DNA accessibility with localized opening at resistance-driving loci, ...

Platinum-based chemotherapy produced delayed, severe GI toxicity and functional decline; clinician reassurance that symptoms ...

Marked underrepresentation of non-White patients persists in ovarian cancer trials, and incomplete race/ethnicity reporting ...

The Food and Drug Administration (FDA) has approved Calquence (acalabrutinib) tablets and capsules in combination with Venclexta (venetoclax) for adults with chronic lymphocytic leukemia (CLL) or ...